Gallant
Stem cell banking for pets
Pitch Details
Season / Episode
S11E8
Nov 17, 2019
Ask
$500,000
for 2%
Ask Valuation
$25M
Deal
$500,000
for 5%
Watch the Pitch
Deal Terms
Amount$500,000
Equity5%
Valuation$10M
Lori Greiner
Anne WojcickiWhat Happened Next
Deal Fell Through
Deal with Lori Greiner and Anne Wojcicki never closed; company raised Series A independently
Thriving
$5.9M
reported
- Deal with Lori Greiner and Anne Wojcicki did not close
- $5M annual revenue as of April 2023
- $15M Series A funding round in January 2024
- Pursuing FDA approval for stem cell therapies, expected 2025
- Valued at $20M as of July 2024
Get updates on Gallant